Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Taurine compound preparation with blood fat reducing function and blood sugar reducing function

A compound preparation, taurine technology, applied in the directions of medical preparations containing active ingredients, antidote, drug combinations, etc., can solve the problems of inducing other diseases, side effects, poor targeting, etc., to reduce blood lipids, improve immunity, significant effect

Active Publication Date: 2014-08-27
SHENYANG AGRI UNIV
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, although there are drugs or compound preparations for lowering blood fat and blood sugar, these drugs have complicated formulas, poor pertinence, unsatisfactory effects, and the main effect drugs are not outstanding enough, and long-term use will cause certain side effects and induce other diseases.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Taurine compound preparation with blood fat reducing function and blood sugar reducing function
  • Taurine compound preparation with blood fat reducing function and blood sugar reducing function

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] Example 1 Capsule dosage form preparation (capsule specification: 0.6g)

[0026] Compound preparation 1 (80% taurine, 7% arginine, 7% gypenosides, 6% vitamin E);

[0027] Composite preparation 2 (83% taurine, 6% arginine, 6% gypenosides, 5% vitamin E);

[0028] Compound preparation 3 (86% of taurine, 5% of arginine, 5% of gypenosides, 4% of vitamin E);

[0029] Weigh the raw materials in proportion, mix them, and pack them into capsules, 0.6g of each drug powder.

Embodiment 2

[0030] Embodiment 2 tablet preparation (tablet specification: 0.6g)

[0031] Compound preparation 1 (80% taurine, 7% arginine, 7% gypenosides, 6% vitamin E);

[0032] Composite preparation 2 (83% taurine, 6% arginine, 6% gypenosides, 5% vitamin E);

[0033] Compound preparation 3 (86% of taurine, 5% of arginine, 5% of gypenosides, 4% of vitamin E);

[0034] The raw materials are weighed in proportion, supplemented with commonly used excipients for tablets to prepare tablets, each 0.6g, wherein the active pharmaceutical ingredients are not less than 80%.

experiment example 1

[0036] In order to verify the effect of the taurine compound preparation for lowering blood fat and blood sugar provided by the present invention, the inventors conducted animal experiments on the medicaments prepared in the above-mentioned Examples 1 and 2. The test methods and results are as follows.

[0037] 1. Animal experiment of auxiliary blood lipid lowering function

[0038] 1.1 Materials and methods

[0039] 1.1.1 Samples tested

[0040] Adopt the compound preparation of the embodiment of the present invention 1 as test sample, but without capsule, direct medicine powder test.

[0041] 1.1.2 Experimental animals and feeding conditions

[0042] SPF-grade healthy male Wistar rats were selected, provided by Beijing Weitong Lihua Experimental Animal Technology Co., Ltd., the test conditions were SPF-grade animal breeding laboratory, and the feeding method was raised in three-dimensional cages, with 5-7 rats per cage, barrier system, indoor The temperature was 18±2°C, t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a taurine compound preparation with a blood fat reducing function and a blood sugar reducing function. The taurine compound preparation comprises, by weight, 80-90 parts of taurine, 2-8 parts of arginine, 2-8 parts of gypenoside and 2-6 parts of Vitamin E. The taurine compound preparation has an antioxidant function, an anti-fatigue function and an immunity enhancement function, the effect is particularly obvious on the aspects of reducing blood fat and blood sugar, clinical tests prove that no toxic action exists on organisms, and thus the compound preparation can be used safely.

Description

technical field [0001] The invention relates to the field of health food, in particular to a taurine compound preparation with functions of lowering blood fat and blood sugar. Background technique [0002] With the improvement of people's living standards and the acceleration of the pace of life, the incidence of chronic diseases such as hyperlipidemia and diabetes is increasing year by year. Hyperglycemia is a typical symptom of diabetes, and hyperlipidemia is an important cause of vascular endothelial damage and dysfunction, which can induce cardiovascular diseases. According to the report of the International Diabetes Federation, there were 336 million diabetics and 280 million pre-diabetics in the world in 2011. In 2011, 4.6 million people died of diabetes worldwide, that is, 1 person died of diabetes every 7 seconds. The "Annual Report on Cardiovascular Diseases in China 2006" issued by the Center for Cardiovascular Diseases Prevention and Control of the Ministry of He...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/424A61P3/06A61P3/10A61P39/06A61P39/00A61P37/04A61K31/185
Inventor 胡建民吴高峰杨建成林树梅秦臻杨群辉冯颖吕秋凤栾新红
Owner SHENYANG AGRI UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com